This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 2005 Sep;54(Pt 9):905-906.

doi: 10.1099/jmm.0.46096-0.

Probiotics for recurrent Clostridium difficile disease

Steven J Lawrence¹, Joshua R Korzenik¹, Linda M Mundy¹

Affiliations

Affiliation

¹ Division of Infectious Diseases, Washington University School of Medicine, Box 8051, 660 South Euclid Avenue, St. Louis, MO 63110, USA 2Division of Gastroenterology, Harvard Medical School, Boston, MA, USA 3Philadelphia FIGHT, Philadelphia, PA, USA 4Saint Louis University School of Public Health, St. Louis, MO, USA.

PMID: 16091446
DOI: 10.1099/jmm.0.46096-0

Clinical Trial

Probiotics for recurrent Clostridium difficile disease

Steven J Lawrence et al. J Med Microbiol. 2005 Sep.

. 2005 Sep;54(Pt 9):905-906.

doi: 10.1099/jmm.0.46096-0.

Authors

Steven J Lawrence¹, Joshua R Korzenik¹, Linda M Mundy¹

Affiliation

¹ Division of Infectious Diseases, Washington University School of Medicine, Box 8051, 660 South Euclid Avenue, St. Louis, MO 63110, USA 2Division of Gastroenterology, Harvard Medical School, Boston, MA, USA 3Philadelphia FIGHT, Philadelphia, PA, USA 4Saint Louis University School of Public Health, St. Louis, MO, USA.

PMID: 16091446
DOI: 10.1099/jmm.0.46096-0

No abstract available

PubMed Disclaimer

Comment on

A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease.
McFarland LV, Surawicz CM, Greenberg RN, Fekety R, Elmer GW, Moyer KA, Melcher SA, Bowen KE, Cox JL, Noorani Z, et al. McFarland LV, et al. JAMA. 1994 Jun 22-29;271(24):1913-8. JAMA. 1994. PMID: 8201735 Clinical Trial.

Similar articles

[Pseudomembranous colitis: pathogenesis, prevention, treatment].
Zakharova NV, Fil' TS. Zakharova NV, et al. Eksp Klin Gastroenterol. 2013;(12):87-91. Eksp Klin Gastroenterol. 2013. PMID: 24933996 Review. Russian.
PROBIOTICS FOR THE PREVENTION OF CLOSTRIDIUM DIFFICILE-ASSOCIATED DIARRHEA IN ADULTS AND CHILDREN.
Gaines C, Moore J. Gaines C, et al. Gastroenterol Nurs. 2019 May/Jun;42(3):299-301. doi: 10.1097/SGA.0000000000000469. Gastroenterol Nurs. 2019. PMID: 31145259 Review. No abstract available.
Rifaximin Redux: treatment of recurrent Clostridium difficile infections with rifaximin immediately post-vancomycin treatment.
Johnson S, Schriever C, Patel U, Patel T, Hecht DW, Gerding DN. Johnson S, et al. Anaerobe. 2009 Dec;15(6):290-1. doi: 10.1016/j.anaerobe.2009.08.004. Epub 2009 Aug 18. Anaerobe. 2009. PMID: 19698797
Probiotics and antibiotic-associated diarrhoea.
Kogan M. Kogan M. Lancet. 2014 Jan 4;383(9911):29. doi: 10.1016/S0140-6736(13)62733-6. Lancet. 2014. PMID: 24388310 No abstract available.
Probiotics and antibiotic-associated diarrhoea.
Kalil AC, Schooneveld TC. Kalil AC, et al. Lancet. 2014 Jan 4;383(9911):29-30. doi: 10.1016/S0140-6736(13)62734-8. Lancet. 2014. PMID: 24388309 No abstract available.

See all similar articles

Cited by

Choosing an appropriate probiotic product for your patient: An evidence-based practical guide.
Sniffen JC, McFarland LV, Evans CT, Goldstein EJC. Sniffen JC, et al. PLoS One. 2018 Dec 26;13(12):e0209205. doi: 10.1371/journal.pone.0209205. eCollection 2018. PLoS One. 2018. PMID: 30586435 Free PMC article.
Lactobacillus delbrueckii ssp. bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cells.
Banerjee P, Merkel GJ, Bhunia AK. Banerjee P, et al. Gut Pathog. 2009 Apr 27;1(1):8. doi: 10.1186/1757-4749-1-8. Gut Pathog. 2009. PMID: 19397787 Free PMC article.
A prospective, interventional, randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of Bacillus coagulans LBSC in the treatment of acute diarrhea with abdominal discomfort.
Maity C, Gupta AK. Maity C, et al. Eur J Clin Pharmacol. 2019 Jan;75(1):21-31. doi: 10.1007/s00228-018-2562-x. Epub 2018 Sep 28. Eur J Clin Pharmacol. 2019. PMID: 30264164 Clinical Trial.
Probiotics in the next-generation sequencing era.
Suez J, Zmora N, Elinav E. Suez J, et al. Gut Microbes. 2020;11(1):77-93. doi: 10.1080/19490976.2019.1586039. Epub 2019 Apr 5. Gut Microbes. 2020. PMID: 30951391 Free PMC article. Review.
Treatment Strategies for Recurrent Clostridium difficile Infection.
Leong C, Zelenitsky S. Leong C, et al. Can J Hosp Pharm. 2013 Nov;66(6):361-8. doi: 10.4212/cjhp.v66i6.1301. Can J Hosp Pharm. 2013. PMID: 24357868 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ingenta plc
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information